Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-96-010763
Filing Date
1996-05-24
Accepted
1996-05-24 00:00:00
Documents
4
SROs
NYSE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 72587
2 EXHIBIT 99.1 - AGREEMENT, ABBOTT LABS AND SONUS EX-99.1 106870
3 EXHIBIT 99.2 - SONUS RIGHTS AGREEMENT EX-99.2 53212
4 EXHIBIT 99.3 - WARRANT CERTIFICATE EX-99.3 13006
  Complete submission text file 0000912057-96-010763.txt   247835
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 (708)-937-61
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45969 | Film No.: 96572181
SIC: 2835 In Vitro & In Vivo Diagnostic Substances